TRAW
Price
$2.95
Change
+$0.05 (+1.72%)
Updated
Oct 14 closing price
Capitalization
21.02M
Intraday Buy/Sell Signals
WHWK
Price
$1.97
Change
-$0.07 (-3.43%)
Updated
Oct 14 closing price
Capitalization
92.84M
21 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

TRAW vs WHWK

Header iconTRAW vs WHWK Comparison
Open Charts TRAW vs WHWKBanner chart's image
Traws Pharma
Price$2.95
Change+$0.05 (+1.72%)
Volume$195.31K
Capitalization21.02M
Whitehawk Therapeutics
Price$1.97
Change-$0.07 (-3.43%)
Volume$301.14K
Capitalization92.84M
TRAW vs WHWK Comparison Chart in %
TRAW
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WHWK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
TRAW vs. WHWK commentary
Oct 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TRAW is a Hold and WHWK is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 15, 2025
Stock price -- (TRAW: $2.95 vs. WHWK: $1.97)
Brand notoriety: TRAW and WHWK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: TRAW: 103% vs. WHWK: 246%
Market capitalization -- TRAW: $21.02M vs. WHWK: $92.84M
TRAW [@Biotechnology] is valued at $21.02M. WHWK’s [@Biotechnology] market capitalization is $92.84M. The market cap for tickers in the [@Biotechnology] industry ranges from $105.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.07B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TRAW’s FA Score shows that 2 FA rating(s) are green whileWHWK’s FA Score has 0 green FA rating(s).

  • TRAW’s FA Score: 2 green, 3 red.
  • WHWK’s FA Score: 0 green, 5 red.
According to our system of comparison, TRAW is a better buy in the long-term than WHWK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TRAW’s TA Score shows that 6 TA indicator(s) are bullish while WHWK’s TA Score has 6 bullish TA indicator(s).

  • TRAW’s TA Score: 6 bullish, 4 bearish.
  • WHWK’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both TRAW and WHWK are a good buy in the short-term.

Price Growth

TRAW (@Biotechnology) experienced а +18.00% price change this week, while WHWK (@Biotechnology) price change was -11.26% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.76%. For the same industry, the average monthly price growth was +13.99%, and the average quarterly price growth was +268.92%.

Reported Earning Dates

WHWK is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+0.76% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
WHWK($92.8M) has a higher market cap than TRAW($21M). WHWK has higher P/E ratio than TRAW: WHWK (11.67) vs TRAW (0.70). WHWK YTD gains are higher at: -37.559 vs. TRAW (-66.779). WHWK has higher annual earnings (EBITDA): -10.21M vs. TRAW (-20.26M). WHWK has more cash in the bank: 177M vs. TRAW (13.1M). WHWK has higher revenues than TRAW: WHWK (21.6M) vs TRAW (2.9M).
TRAWWHWKTRAW / WHWK
Capitalization21M92.8M23%
EBITDA-20.26M-10.21M198%
Gain YTD-66.779-37.559178%
P/E Ratio0.7011.676%
Revenue2.9M21.6M13%
Total Cash13.1M177M7%
Total DebtN/A0-
FUNDAMENTALS RATINGS
TRAW vs WHWK: Fundamental Ratings
TRAW
WHWK
OUTLOOK RATING
1..100
6323
VALUATION
overvalued / fair valued / undervalued
1..100
25
Undervalued
55
Fair valued
PROFIT vs RISK RATING
1..100
10096
SMR RATING
1..100
10095
PRICE GROWTH RATING
1..100
3943
P/E GROWTH RATING
1..100
1145
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TRAW's Valuation (25) in the Biotechnology industry is in the same range as WHWK (55) in the Pharmaceuticals Major industry. This means that TRAW’s stock grew similarly to WHWK’s over the last 12 months.

WHWK's Profit vs Risk Rating (96) in the Pharmaceuticals Major industry is in the same range as TRAW (100) in the Biotechnology industry. This means that WHWK’s stock grew similarly to TRAW’s over the last 12 months.

WHWK's SMR Rating (95) in the Pharmaceuticals Major industry is in the same range as TRAW (100) in the Biotechnology industry. This means that WHWK’s stock grew similarly to TRAW’s over the last 12 months.

TRAW's Price Growth Rating (39) in the Biotechnology industry is in the same range as WHWK (43) in the Pharmaceuticals Major industry. This means that TRAW’s stock grew similarly to WHWK’s over the last 12 months.

TRAW's P/E Growth Rating (11) in the Biotechnology industry is somewhat better than the same rating for WHWK (45) in the Pharmaceuticals Major industry. This means that TRAW’s stock grew somewhat faster than WHWK’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
TRAWWHWK
RSI
ODDS (%)
Bearish Trend 8 days ago
85%
Bearish Trend 8 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 8 days ago
81%
Bearish Trend 8 days ago
75%
Momentum
ODDS (%)
Bullish Trend 8 days ago
74%
Bullish Trend 8 days ago
79%
MACD
ODDS (%)
Bullish Trend 8 days ago
67%
Bullish Trend 8 days ago
74%
TrendWeek
ODDS (%)
Bullish Trend 8 days ago
80%
Bullish Trend 8 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 8 days ago
79%
Bullish Trend 8 days ago
78%
Advances
ODDS (%)
Bullish Trend about 1 month ago
77%
Bullish Trend 9 days ago
79%
Declines
ODDS (%)
Bearish Trend 22 days ago
90%
Bearish Trend 16 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 8 days ago
86%
Bearish Trend 8 days ago
77%
Aroon
ODDS (%)
Bullish Trend 8 days ago
84%
Bullish Trend 8 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
TRAW
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WHWK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MCB79.012.99
+3.93%
Metropolitan Bank Holding Corp
FF3.840.10
+2.67%
Future Fuel Corp
VTR67.960.51
+0.76%
Ventas
TENB29.22-0.12
-0.41%
Tenable Holdings
SMX1.21-0.07
-5.47%
SMX (Security Matters) Public Limited Company

TRAW and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRAW has been loosely correlated with SLGL. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if TRAW jumps, then SLGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRAW
1D Price
Change %
TRAW100%
+1.72%
SLGL - TRAW
45%
Loosely correlated
-0.50%
RAPT - TRAW
45%
Loosely correlated
-5.12%
WHWK - TRAW
39%
Loosely correlated
-3.43%
AVXL - TRAW
35%
Loosely correlated
+2.03%
RXRX - TRAW
29%
Poorly correlated
+6.51%
More

WHWK and

Correlation & Price change

A.I.dvisor indicates that over the last year, WHWK has been closely correlated with ELVAF. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if WHWK jumps, then ELVAF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WHWK
1D Price
Change %
WHWK100%
-3.43%
ELVAF - WHWK
76%
Closely correlated
N/A
DMAC - WHWK
44%
Loosely correlated
-2.97%
TRAW - WHWK
39%
Loosely correlated
+1.72%
CLYYF - WHWK
37%
Loosely correlated
N/A
PRLD - WHWK
35%
Loosely correlated
+4.00%
More